P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism

Oncogene

Volumn 30, Issue 41, 2011, Pages 4219-4230

  Al Bahlani, S ^a,b   Fraser, M ^a,f   Wong, A Y C ^a   Sayan, B S ^c   Bergeron, R ^a,d   Melino, G ^c,e   Tsang, B K ^a,d,g  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b SULTAN QABOOS UNIVERSITY   (Oman)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d UNIVERSITY OF OTTAWA   (Canada)

^e LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^f PRINCESS MARGARET HOSPITAL   (Canada)

^g Seoul National University   (South Korea)

Author keywords

calcium; calpain; CDDP; ovarian cancer; p73a

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; CALCIUM; CALPAIN; CISPLATIN; CYCLOPIAZONIC ACID; MESSENGER RNA; PROTEIN P73;

APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CALCIUM; CALPAIN; CELL LINE, TUMOR; CISPLATIN; CYSTEINE PROTEINASE INHIBITORS; DIPEPTIDES; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IMMUNOPRECIPITATION; INTRACELLULAR SPACE; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 80054023857     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.134     Document Type: Article

References (50)

1. Abedini MR, Muller EJ, Bergeron R, Gray DA, Tsang BK. (2010). Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein. Oncogene 29: 11-25.
2. Abedini MR, Muller EJ, Brun J, Bergeron R, Gray DA, Tsang BK. (2008). Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells. Cancer Res 68: 4511-4517.
3. Aqeilan RI, Pekarsky Y, Herrero JJ, Palamarchuk A, Letofsky J, Druck T et al. (2004). Functional association between Wwox tumor suppressor protein and p73, a p53 homolog. Proc Natl Acad Sci USA 101: 4401-4406. (Pubitemid 38437424)
4. Bergamaschi D, Samuels Y, Jin B, Duraisingham S, Crook T, Lu X. (2004). ASPP1 and ASPP2: common activators of p53 family members. Mol Cell Biol 24: 1341-1350. (Pubitemid 38112194)
5. Bernassola F, Karin M, Ciechanover A, Melino G. (2008). The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell 14: 10-21. (Pubitemid 351885498)
6. Bernassola F, Salomoni P, Oberst A, Di Como CJ, Pagano M, Melino G et al. (2004). Ubiquitin-dependent degradation of p73 is inhibited by PML. J Exp Med 199: 1545-1557. (Pubitemid 38780409)
7. Chen CL, Ip SM, Cheng D, Wong LC, Ngan HY. (2000). P73 gene expression in ovarian cancer tissues and cell lines. Clin Cancer Res 6: 3910-3915.
8. Di Sano F, Ferraro E, Tufi R, Achsel T, Piacentini M, Cecconi F. (2006). Endoplasmic reticulum stress induces apoptosis by an apoptosome-dependent but caspase 12-independent mechanism. J Biol Chem 281: 2693-2700. (Pubitemid 43845732)
9. Eltabbakh GH, Awtrey CS. (2001). Current treatment for ovarian cancer. Expert Opin Pharmacother 2: 109-124. (Pubitemid 32427718)
10. Fontemaggi G, Kela I, Amariglio N, Rechavi G, Krishnamurthy J, Strano S et al. (2002). Identification of direct p73 target genes combining DNA microarray and chromatin immunoprecipitation analyses. J Biol Chem 277: 43359-43368. (Pubitemid 35285724)
11. Fraser M, Bai T, Tsang BK. (2008). Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphor-ylation and nuclear function. Int J Cancer 122: 534-546. (Pubitemid 350308944)
12. Fraser M, Leung B, Jahani-Asl A, Yan X, Thompson WE, Tsang BK. (2003a). Chemoresistance in human ovarian cancer: the role of apoptotic regulators. Reprod Biol Endocrinol 1: 66.
13. Fraser M, Leung BM, Yan X, Dan HC, Cheng JQ, Tsang BK. (2003b). p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells. Cancer Res 63: 7081-7088. (Pubitemid 37413443)
14. Gao G, Dou QP. (2000). N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome C release and apoptotic cell death. J Cell Biochem 80: 53-72.
15. Grob TJ, Novak U, Maisse C, Barcaroli D, Luthi AU, Pirnia F et al. (2001). Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ 8: 1213-1223. (Pubitemid 34048476)
16. Gunes DA, Florea AM, Splettstoesser F, Busselberg D. (2009). Co-application of arsenic trioxide (As(2)O(3)) and cisplatin (CDDP) on human SY-5Y neuroblastoma cells has differential effects on the intracellular calcium concentration ([Ca(2+)](i)) and cytotoxicity. Neurotoxicology 30: 194-202.
17. Holcakova J, Ceskova P, Hrstka R, Muller P, Dubska L, Coates PJ et al. (2008). The cell type-specific effect of TAp73 isoforms on the cell cycle and apoptosis. Cell Mol Biol Lett 13: 404-420.
18. Irwin MS. (2004). Family feud in chemosensitivity: p73 and mutant p53. Cell Cycle 3: 319-323. (Pubitemid 41363625)
19. Irwin MS, Kondo K, Marin MC, Cheng LS, Hahn WC, Kaelin Jr WG. (2003). Chemosensitivity linked to p73 function. Cancer Cell 3: 403-410. (Pubitemid 38340308)
20. Kartasheva NN, Contente A, Lenz-Stoppler C, Roth J, Dobbelstein M. (2002). p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop. Oncogene 21: 4715-4727. (Pubitemid 34879447)
21. Kobayashi S, Yamashita K, Takeoka T, Ohtsuki T, Suzuki Y, Takahashi R et al. (2002). Calpain-mediated X-linked inhibitor of apoptosis degradation in neutrophil apoptosis and its impairment in chronic neutrophilic leukemia. J Biol Chem 277: 33968-33977.
22. Liu G, Nozell S, Xiao H, Chen X. (2004). DeltaNp73beta is active in transactivation and growth suppression. Mol Cell Biol 24: 487-501. (Pubitemid 38057903)
23. Marabese M, Marchini S, Sabatino MA, Polato F, Vikhanskaya F, Marrazzo E et al. (2005). Effects of inducible overexpression of DNp73alpha on cancer cell growth and response to treatment in vitro and in vivo. Cell Death Differ 12: 805-814. (Pubitemid 40945987)
24. Melino G, Bernassola F, Ranalli M, Yee K, Zong WX, Corazzari M et al. (2004). p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. J Biol Chem 279: 8076-8083. (Pubitemid 38294697)
25. Melino G, De Laurenzi V, Vousden KH. (2002). p73: friend or foe in tumorigenesis. Nat Rev Cancer 2: 605-615. (Pubitemid 37328927)
26. Melino G, Lu X, Gasco M, Crook T, Knight RA. (2003). Functional regulation of p73 and p63: development and cancer. Trends Biochem Sci 28: 663-670. (Pubitemid 37500901)
27. Million K, Horvilleur E, Goldschneider D, Agina M, Raguenez G, Tournier F et al. (2006). Differential regulation of p73 variants in response to cisplatin treatment in SH-SY5Y neuroblastoma cells. Int J Oncol 29: 147-154.
28. Moncoq K, Trieber CA, Young HS. (2007). The molecular basis for cyclopiazonic acid inhibition of the sarcoplasmic reticulum calcium pump. J Biol Chem 282: 9748-9757. (Pubitemid 47104607)
29. Monteith GR, McAndrew D, Faddy HM, Roberts-Thomson SJ. (2007). Calcium and cancer: targeting Ca2+ transport. Nat Rev Cancer 7: 519-530. (Pubitemid 46985398)
30. Muller M, Schilling T, Sayan AE, Kairat A, Lorenz K, Schulze-Bergkamen H et al. (2005). TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death Differ 12: 1564-1577. (Pubitemid 41679162)
31. Muller M, Schleithoff ES, Stremmel W, Melino G, Krammer PH, Schilling T. (2006). One, two, three-p53, p63, p73 and chemo-sensitivity. Drug Resist Updat 9: 288-306.
32. Munarriz E, Bano D, Sayan AE, Rossi M, Melino G, Nicotera P. (2005). Calpain cleavage regulates the protein stability of p73. Biochem Biophys Res Commun 333: 954-960. (Pubitemid 40854249)
33. Muscolini M, Cianfrocca R, Sajeva A, Mozzetti S, Ferrandina G, Costanzo A et al. (2008). Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells. Mol Cancer Ther 7: 1410-1419.
34. Nyman U, Sobczak-Pluta A, Vlachos P, Perlmann T, Zhivotovsky B, Joseph B. (2005). Full-length p73alpha represses drug-induced apoptosis in small cell lung carcinoma cells. J Biol Chem 280: 34159-34169. (Pubitemid 41443140)
35. Ozaki T, Nakagawara A. (2005). p73, a sophisticated p53 family member in the cancer world. Cancer Sci 96: 729-737. (Pubitemid 43019823)
36. Perrin BJ, Huttenlocher A. (2002). Calpain. Int J Biochem Cell Biol 34: 722-725. (Pubitemid 34304162)
37. Pietsch EC, Sykes SM, McMahon SB, Murphy ME. (2008). The p53 family and programmed cell death. Oncogene 27: 6507-6521.
38. Ramadan S, Terrinoni A, Catani MV, Sayan AE, Knight RA, Mueller M et al. (2005). p73 induces apoptosis by different mechanisms. Biochem Biophys Res Commun 331: 713-717. (Pubitemid 40615502)
39. Righetti SC, Perego P, Carenini N, Zunino F. (2008). Cooperation between p53 and p73 in cisplatin-induced apoptosis in ovarian carcinoma cells. Cancer Lett 263: 140-144.
40. Rossi M, De Laurenzi V, Munarriz E, Green DR, Liu YC, Vousden KH et al. (2005). The ubiquitin-protein ligase Itch regulates p73 stability. EMBO J 24: 836-848. (Pubitemid 40396112)
41. Sabatino MA, Previdi S, Broggini M. (2007). In vivo evaluation of the role of DNp73alpha protein in regulating the p53-dependent apoptotic pathway after treatment with cytotoxic drugs. Int J Cancer 120: 506-513. (Pubitemid 44969020)
42. Sang M, Ando K, Okoshi R, Koida N, Li Y, Zhu Y et al. (2009). Plk3 inhibits pro-apoptotic activity of p73 through physical interaction and phosphorylation. Genes Cells 14: 775-788.
43. Sayan AE, Paradisi A, Vojtesek B, Knight RA, Melino G, Candi E. (2005). New antibodies recognizing p73: comparison with commercial antibodies. Biochem Biophys Res Commun 330: 186-193. (Pubitemid 40394951)
44. Shaw TJ, Senterman MK, Dawson K, Crane CA, Vanderhyden BC. (2004). Characterization of intraperitoneal, orthotopic, and meta-static xenograft models of human ovarian cancer. Mol Ther 10: 1032-1042. (Pubitemid 39625247)
45. Splettstoesser F, Florea AM, Busselberg D. (2007). IP(3) receptor antagonist, 2-APB, attenuates cisplatin induced Ca2+-influx in HeLa-S3 cells and prevents activation of calpain and induction of apoptosis. Br J Pharmacol 151: 1176-1186. (Pubitemid 47255902)
46. Sullivan A, Lu X. (2007). ASPP: a new family of oncogenes and tumour suppressor genes. Br J Cancer 96: 196-200. (Pubitemid 46160620)
47. Toyota H, Yanase N, Yoshimoto T, Moriyama M, Sudo T, Mizuguchi J. (2003). Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type Bax. Cancer Lett 189: 221-230. (Pubitemid 35461998)
48. Vayssade M, Haddada H, Faridoni-Laurens L, Tourpin S, Valent A, Benard J et al. (2005). P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cells. Int J Cancer 116: 860-869. (Pubitemid 41209191)
49. Vikhanskaya F, Marchini S, Marabese M, Galliera E, Broggini M. (2001). P73a overexpression is associated with resistance to treatment with DNA-damaging agents in a human ovarian cancer cell line. Cancer Res 61: 935-938. (Pubitemid 32174407)
50. Yoshida K, Ozaki T, Furuya K, Nakanishi M, Kikuchi H, Yamamoto H et al. (2008). ATM-dependent nuclear accumulation of IKK-alpha plays an important role in the regulation of p73-mediated apoptosis in response to cisplatin. Oncogene 27: 1183-1188. (Pubitemid 351253185)